An exploratory study of susceptible factors to tolvaptan treatment in hepatic edema
Not Applicable
- Conditions
- iver cirrhosis with refractory hepatic edema
- Registration Number
- JPRN-UMIN000017318
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Tokai University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Alcoholic hepatitis and cirrhosis patients in continued drinking 2)Patients with overt hepatic encephalopathy 3)Patients with requiring treatment for esophageal, gastric or rectal varices 4)Hepatocellular carcinoma with life expectancy less than 3 months 5)The anuria patints (including dialysis patients) 6)Patients with urinary excretion failure 7)Patients with oral intake difficulty 8)Patients receiving albumin within 7 days before the test 9)Patients with unsuitable condition for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method